Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.1706 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.0896 | 46 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.1217 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.0552 | 47 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.04668 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.18664 | 46 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.3492 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.01838 | 44 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.09885 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.1014 | 47 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.1009 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.10157 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.11569 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.15756 | 49 |